New Directions in
Small Vessel Vasculitis -
ANCA, Target Organs,
Treatment, and Beyond
Webcast and Journal Supplement Series
Vasculitis is an often under-recognized group of diseases that can have a diverse range of presentations. Delays in diagnosis can result in organ injury, which can have serious long-term consequences, some life-threatening. Small vessel vasculitis in particular can be associated with severe outcomes and present challenges in diagnosis.
This webcast series and online Cleveland Clinic Journal of Medicine supplement, "New Directions in Small Vessel Vasculitis — ANCA, Target Organs, Treatment, and Beyond," present in-depth reviews and discussions of our current understanding of the clinical features, diagnostic methodology, monitoring, and treatment of patients with small-vessel vasculitis. The goal of the webcast series and journal supplement is to improve the knowledge, comprehension, and skills of practitioners. The series and supplement offer detailed analyses of the following:
- Small vessel vasculitis: Clinical features and diagnosis.
- Impact of vasculitis on individual organ systems.
- Patient safety issues in vasculitis.
- Treatment of vasculitis – conventional immunosuppressive agents and biologic therapies.
This Series has expired.
You will be redirected to the Cleveland Clinic Center for Continuing Education Home page to find related content.